<code id='51E9E0B368'></code><style id='51E9E0B368'></style>
    • <acronym id='51E9E0B368'></acronym>
      <center id='51E9E0B368'><center id='51E9E0B368'><tfoot id='51E9E0B368'></tfoot></center><abbr id='51E9E0B368'><dir id='51E9E0B368'><tfoot id='51E9E0B368'></tfoot><noframes id='51E9E0B368'>

    • <optgroup id='51E9E0B368'><strike id='51E9E0B368'><sup id='51E9E0B368'></sup></strike><code id='51E9E0B368'></code></optgroup>
        1. <b id='51E9E0B368'><label id='51E9E0B368'><select id='51E9E0B368'><dt id='51E9E0B368'><span id='51E9E0B368'></span></dt></select></label></b><u id='51E9E0B368'></u>
          <i id='51E9E0B368'><strike id='51E9E0B368'><tt id='51E9E0B368'><pre id='51E9E0B368'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:5618

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          The high personal cost of affirmative action for Black doctors
          The high personal cost of affirmative action for Black doctors

          MikeReddyforSTATIshouldbeirateanddespondentabouttheSupremeCourt’sscrappingofaffirmativeactioninadmis

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          Readout Newsletter: BridgeBio, Akero, and human embryo models

          WellcomeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletteri